Evidence Based Medicine on FHIR Implementation Guide, published by HL7 International / Clinical Decision Support. This guide is not an authorized publication; it is the continuous build for version 2.0.0-ballot built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/ebm/ and changes regularly. See the Directory of published versions
Generated Narrative: Evidence 47771
version: 10; Last updated: 2023-12-06 17:48:14+0000
Profiles: ComparativeEvidence, SingleStudyEvidence
url: https://fevir.net/resources/Evidence/47771
identifier: FEvIR Object Identifier/47771
name: ComparativeEvidence_Mean_difference_in_HbA1c_between_Surgery_and_Medical_Lifestyle_groups_in_Schauer_2014_STAMPEDE_trial
title: ComparativeEvidence: Mean difference in HbA1c between Surgery and Medical/Lifestyle groups in Schauer 2014 (STAMPEDE) trial
status: Active
date: 2022-05-29 11:09:40+0000
publisher: Computable Publishing LLC
contact: support@computablepublishing.com
author: Brian S. Alper:
Code | Value[x] |
Evidence Based Medicine on FHIR Implementation Guide Code System evidence-communication: Evidence Communication | ComparativeEvidence |
Evidence Based Medicine on FHIR Implementation Guide Code System evidence-communication: Evidence Communication | SingleStudyEvidence |
copyright:
https://creativecommons.org/licenses/by-nc-sa/4.0/
relatedArtifact
type: Derived From
label: data source
display: Figure 2C
citation:
Metabolic Surgery in the Treatment Algorithm for Type 2 Diabetes: A Joint Statement by International Diabetes Organizations [Journal Article]. Contributors: Francesco Rubino, David M Nathan, Robert H Eckel, Philip R Schauer, K George M M Alberti, Paul Z Zimmet, Stefano Del Prato, Linong Ji, Shaukat M Sadikot, William H Herman, Stephanie A Amiel, Lee M Kaplan, Gaspar Taroncher-Oldenburg, David E Cummings, Delegates of the 2nd Diabetes Surgery Summit. In: Diabetes care, PMID 27222544. Published June 2016. Available at: https://pubmed.ncbi.nlm.nih.gov/27222544/.
Documents
Url https://diabetesjournals.org/care/article/39/6/861/29305/Metabolic-Surgery-in-the-Treatment-Algorithm-for
relatedArtifact
type: Cite As
citation:
ComparativeEvidence: Mean difference in HbA1c between Surgery and Medical/Lifestyle groups in Schauer 2014 (STAMPEDE) trial [Evidence]. Contributors: Brian S. Alper [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 47771. Revised 2022-05-29. Available at: https://fevir.net/resources/Evidence/47771. Computable resource at: https://fevir.net/resources/Evidence/47771.
description:
Mean HbA1c at 36 months in Schauer 2014 was 6.85% in Surgery group (n = 97) and 8.4% in Medical/Lifestyle group (n = 40), mean difference -1.55% (95% CI -2.28% to -0.82%)
variableDefinition
description:
137 with uncontrolled T2DM
variableRole: Population
observed: Schauer 2014 (STAMPEDE) Trial Enrollment Group
variableDefinition
description:
Roux-en-Y gastric bypass or Sleeve Gastrectomy vs. medical treatment (intensive medical therapy)
variableRole: Exposure
comparatorCategory: medical treatment
observed: GroupAssignment: Roux-en-Y gastric bypass vs. medical treatment
variableDefinition
description:
HbA1c at 36 months
variableRole: Outcome
observed: OutcomeVariable: HbA1c at 36 months
synthesisType: not applicable
studyDesign: randomized assignment
statistic
description:
mean difference --1.55% (95% CI -2.28% to -0.82%)
note: Mean HbA1c at 36 months in Schauer 2014 was 6.85% in Surgery group (n = 97) and 8.4% in Medical/Lifestyle group (n = 40)
statisticType: Mean Difference
quantity: -1.55 % (Details: UCUM code% = '%')
SampleSizes
NumberOfParticipants KnownDataCount 137 137 AttributeEstimates
Description Type Level Range 95% CI -2.28% to -0.82%
Confidence interval 0.95 -2.28--0.82 %